Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

Two years after facing criticism that its clinical trials office was in “profound disarray,” UC San Diego Moores Cancer ...

The author has a $2.75 Price Target on CytoDyn (CYDY) in the Next 6 to 12 months, representing significant upside from its ...

An international expert panel has developed the first consensus criteria for referral criteria for specialist palliative care ...

A health care workers union sued Kaiser Permanente’s Colorado branch in October 2021, alleging the company violated its ...

In a nutshell One injection of zilebesiran every six months could replace daily blood pressure pills for some patients ...

Gaza faces severe medical supply shortages; Australia's Healthscope seeks buyers amid financial woes; Roche advances a ...

The American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) published the new Clinical Practice ...

Misinterpretation of MRI findings by clinicians focused on earlier intervention is leading to increased rates of ...

ACOG’s new guidance on transforming prenatal care in the United States took center stage at the organization’s annual ...

We’re witnessing a renaissance in cytokine targeting,” says Dr. Emily Rhodes, immunologist at the Stanford Institute for ...

The American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) published the new Clinical Practice Guideline (CPG): Surgical Management of Chronic Rhinosinusitis today in ...